Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and...
Fundamental
Quidel: a manufacturer of diagnostic products, frequently rises or sinks in response to developments in the coronavirus pandemic, as a big part of their revenue comes from its COVID-19 testing kits.
As the Delta Variant is worrying countries around the globe, QDEL will be interesting to watch.
Technical Analysis
As you can see in the weekly ...
"Quidel has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to market its Easy-to-use test that provides results in 15 minutes is now available without a prescription".
Quidel (QDEL) is cheap for me now.
The market somewhat exaggerated its sale.
This company has a lot to offer even after the COVID crisis. Are there any other positive news and their balance sheet?
Research yourself, strong company!
Iam in at 125.5 and waitin for some good premium, expect a mild pump on Monday, but I'm waiting for at least a 50-100 %...
$QDEL did a new high, RSI did too. Volume is far above the average.
12 months Consensus Price Target: $117
if you find my charts useful, please leave me "like" or "comment".
Please don't trade according to the ideas, rely on your own knowledge.
Thx
